National Policy on R&D, Innovation to Boost Pharma-Medtech Sector: Dr S Narasimha Murthy September 22, 2023 The new national policy paves the way for a notable increase in originality, entrepreneurship, and new inventive treatment methods in the pharmaceutical and medtech sectors.
Union Cabinet Approves INR 5000 Cr PRIP Scheme to Boost R&D in Pharma-MedTech Sector September 4, 2023 The PRIP scheme is poised to support collaboration among pharmaceutical companies, research and innovation institutions, and start-up ventures, as it receives an allocation of INR 5,000 Cr from the Cabinet.
Page 1 of 1